Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.19% | 163.53 | 0.7% | $1333.35m | |
| LLY | Eli Lilly & Co. | 0.74% | 323.99 | 1.1% | $1075.80m | |
| ABBV | AbbVie, Inc. | 0.94% | 139.60 | 1.9% | $860.15m | |
| PFE | Pfizer Inc. | 0.48% | 44.32 | 0.9% | $801.41m | |
| BMY | Bristol-Myers Squibb Co. | -0.01% | 70.53 | 1.0% | $772.67m | |
| MRK | Merck & Co., Inc. | 0.46% | 87.96 | 0.7% | $713.70m | |
| AZN | AstraZeneca Plc | 1.58% | 56.43 | 1.0% | $393.63m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 196.79 | 8.2% | $217.39m | |
| GSK | GSK Plc | 1.75% | 30.76 | 0.3% | $213.18m | |
| NVS | Novartis AG | 1.67% | 77.95 | 0.2% | $205.02m | |
| ATXI | Avenue Therapeutics, Inc. | 41.70% | 16.31 | 0.0% | $197.40m | |
| GBT | Global Blood Therapeutics, Inc. | 0.00% | 68.48 | 5.4% | $191.16m | |
| IDXX | IDEXX Laboratories, Inc. | 1.10% | 340.39 | 3.9% | $186.31m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 64.26 | 5.4% | $173.65m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.00% | 109.94 | 12.4% | $136.73m |
Company Profile
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.